USFDA inspects Dahej facility, no observations issued: Ajanta Pharma

USFDA inspects Dahej facility, no observations issued: Ajanta Pharma US Food Drug Administration (USFDA) issues Form 483 to a company#39;s management after completion of inspection of its facility to notify regarding objectionable conditions.

No comments:

Post a Comment